The management recommendation for both acquired premature ejaculation (APE) and lifelong PE (LPE) are similar, such as a behavioral/psychotherapy, a pharmacotherapy and a combination of these treatments. For the drug treatment for PE, gold standard is selective serotonin reuptake inhibitors (SSRIs) including dapoxetine or paroxetine. The drug treatment for PE is still developing and some new promising therapeutic options have been proposed. Topical anesthetics, tramadol, and alpha-1 blockers will be the next strategies of the drug treatment for PE in the future.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001998 | PMC |
| http://dx.doi.org/10.21037/tau.2016.06.10 | DOI Listing |
Publication Analysis
Top Keywords
drug treatment
16
premature ejaculation
8
drug
4
treatment premature
4
ejaculation management
4
management recommendation
4
recommendation acquired
4
acquired premature
4
ejaculation ape
4
ape lifelong
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!